Angina Pectoris: clinical trials and information
Angina Pectoris clinical trials in Canada
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina NCT01659580 | Completed | Phase 3 | British Columbia, Ontario, Quebec | Tasly Pharmaceuticals, Inc. | 2012-08 |
| Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) NCT01442038 | Completed | Phase 3 | Alberta, New Brunswick, Ontario, Quebec | Gilead Sciences | 2011-10 |
| Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina NCT01425359 | Completed | Phase 4 | Ontario, Quebec | Gilead Sciences | 2011-09 |
Angina Pectoris clinical trials worldwide (outside Canada)
21 trials, 2 recruiting or not yet recruiting. Recruiting first.
About Angina Pectoris
What is Angina Pectoris?
"Angina Pectoris" is the term study registrants used on ClinicalTrials.gov. Registry labels are not always standard medical terms, and close variants of the same label appear as separate entries. In this snapshot the term appears on 24 chronic pain registry records worldwide.
How is Angina Pectoris usually assessed?
Assessment of chronic pain generally involves a clinician taking a detailed history, a physical examination and, where relevant, tests to look for underlying causes. Pain rating scales and questionnaires about function, sleep and mood are often used. The approach depends on the person and the condition.
What kinds of treatments are studied for Angina Pectoris?
Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.
How can I find Angina Pectoris clinical trials in Canada?
This page lists 3 registry records for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.
Related conditions
Related interventions
Related US FDA drug labels
Labels whose indications text mentions this term. US labels, not Health Canada Product Monographs.
- Dehydrated Alcohol Injection
- FDA drug label 1d0a512a
- Dehydrated Alcohol Injection
- Dehydrated Alcohol Injection, USP
- Dehydrated Alcohol Injection, USP
- Dehydrated Alcohol Injection
- Dehydrated Alcohol Injection
- Dehydrated Alcohol Injection
- FDA drug label 5437ccae
- Dehydrated Alcohol Injection, USP
- FDA drug label 5a448eff
- Dehydrated Alcohol Injection
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.